About this trial
The aim of this single-blind randomized controlled trial is to compare the effects of two therapies-neuromuscular electrical stimulation (NMES) and electromyographic (EMG) biofeedback-in stroke patients with shoulder (glenohumeral) subluxation.
The study will evaluate changes in shoulder structure and function by measuring the acromion-greater tuberosity distance, supraspinatus and posterior deltoid muscle thickness, shoulder range of motion, and Brunnstrom stage of the upper extremity and hand. Clinical outcomes such as shoulder pain, stroke-specific quality of life, and the Shoulder Pain and Disability Index (SPADI) will also be assessed.
This trial is designed to provide evidence on which therapy may be more effective for improving shoulder stability, reducing pain, and enhancing quality of life in stroke survivors with shoulder subluxation.
Eligibility criteria
Qualifiers
≥18 years of age,
Disease duration >3 months,
Glenohumeral subluxation (GHS) confirmed by ultrasonography (USG),
Upper extremity and hand Brunnstrom motor stages between 2 and 5
Disqualifiers
Mini-Mental State Examination (MMSE) score <24,
Visual/hearing impairments, or neglect,
Steroid injection for shoulder pain within the last 3 months,
Unstable systemic disease,
Trial design
Treatments tested in this trial
- Neuromuscular electrical stimulation
- Electromyographic (EMG) biofeedback
- Conventional physiotherapy
Treatment groups
Sponsors and collaborators
Şahide Eda ARTUÇ
Lead sponsor
Turkish League Against Rheumatism
Sponsor institution